Loading...

IART INTEGRA LIFESCIENCES HOLDINGS CORP Operational Disruptions 8-K Filing

NTGR

RT

INTEGRA LIFESCIENCES HOLDINGS CORP

(IART)

2023 8-K

Show Summary

Summary

Debt-Equity Swaps

Financial Statements

Earnings Announcement

FDA Warning Letter

Severance Program

Q3 2024 Results

CEO Appointment

Financial Results Announcement

Share Repurchase Agreement

Annual Meeting and Share Re...

Financial Results Announcement

Retirement and Appointment

Financial Results Announcement

Amendment to Filing

Agreement Amendment

Appointment of Director, Ch...

Acquisition Agreement

Financial Results Announcement

Share Repurchase Agreement

Financial Results and FDA W...

Appointment of CFO

Material Impairments

Annual Meeting of Stockholders

Financial Results

External Links:

Integra Lifesciences Holdings Corp initiated a voluntary global recall of products manufactured in its Boston facility and expects to incur an impairment charge of approximately $22 million.

AI Assistant

INTEGRA LIFESCIENCES HOLDINGS CORP

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.